Cargando…
Integrative analysis of CRISPR screening data uncovers new opportunities for optimizing cancer immunotherapy
BACKGROUND: In recent years, the application of functional genetic immuno-oncology screens has showcased the striking ability to identify potential regulators engaged in tumor-immune interactions. Although these screens have yielded substantial data, few studies have attempted to systematically aggr...
Autores principales: | Li, Yan, Yang, Chen, Liu, Zhicheng, Du, Shangce, Can, Susan, Zhang, Hailin, Zhang, Linmeng, Huang, Xiaowen, Xiao, Zhenyu, Li, Xiaobo, Fang, Jingyuan, Qin, Wenxin, Sun, Chong, Wang, Cun, Chen, Jun, Chen, Huimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722047/ https://www.ncbi.nlm.nih.gov/pubmed/34980132 http://dx.doi.org/10.1186/s12943-021-01462-z |
Ejemplares similares
-
A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer
por: Yang, Chen, et al.
Publicado: (2022) -
Mapping the landscape of synthetic lethal interactions in liver cancer
por: Yang, Chen, et al.
Publicado: (2021) -
Combating inconsistent evaluation of intra-tumor immune status by a novel transcriptomic signature in hepatocellular carcinoma
por: Zhang, Linmeng, et al.
Publicado: (2023) -
Multi-region sequencing with spatial information enables accurate heterogeneity estimation and risk stratification in liver cancer
por: Yang, Chen, et al.
Publicado: (2022) -
Metabolism‐associated molecular classification of hepatocellular carcinoma
por: Yang, Chen, et al.
Publicado: (2020)